109903-35-7 Usage
Description
4-Amino-N-methylbenzenemethanesulfonamide is an organic compound that serves as a crucial intermediate in the pharmaceutical industry. It is characterized by its chemical structure, which includes an amino group, a methyl group, and a benzene ring attached to a methanesulfonamide group. 4-Amino-N-methylbenzenemethanesulfonamide plays a significant role in the synthesis of various pharmaceutical products due to its unique reactivity and functional groups.
Uses
Used in Pharmaceutical Industry:
4-Amino-N-methylbenzenemethanesulfonamide is used as an intermediate in the synthesis of Sumatriptan (S810000), a medication primarily used to treat migraine headaches. It is particularly effective in alleviating the symptoms of migraines, such as severe headaches, nausea, and sensitivity to light and sound. The compound's role in the synthesis of Sumatriptan highlights its importance in the development of medications for neurological disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 109903-35-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,9,9,0 and 3 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 109903-35:
(8*1)+(7*0)+(6*9)+(5*9)+(4*0)+(3*3)+(2*3)+(1*5)=127
127 % 10 = 7
So 109903-35-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H12N2O2S/c1-10-13(11,12)6-7-2-4-8(9)5-3-7/h2-5,10H,6,9H2,1H3
109903-35-7Relevant articles and documents
INHIBITORS OF PROTEIN KINASES
-
Page/Page column 22; 24, (2010/08/07)
The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).
INHIBITORS OF PROTEIN KINASES
-
Page/Page column 49, (2008/12/08)
The present invention provides new compounds. The compounds are useful as CDK5 inhibitors, and accordingly they can be included in pharmaceuticals compositions for treating any type of pain, inflammatory disorders, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases and neurodegenerative diseases. formula (I).